• price to sales forward of scopus biopharma, inc. – otc:scps TradingView Sat, 27 Jun 2026 14:29:10 GMT
• Enterprise value to EBITDA forward of Scopus Biopharma, Inc. – OTC:SCPS TradingView Sat, 27 Jun 2026 05:16:40 GMT
• price to earnings forward of scopus biopharma, inc. – otc:scps TradingView Fri, 26 Jun 2026 21:03:25 GMT
• enterprise value to revenue forward of scopus biopharma, inc. – otc:scps TradingView Fri, 26 Jun 2026 11:46:26 GMT
• scopus biopharma inc. (scps) stock price, news, quote & history Yahoo Finance Fri, 27 Mar 2026 20:00:00 GMT
• pharmaceutical and biotechnology royalty rates agreements GlobeNewswire Thu, 12 Mar 2026 07:00:00 GMT
• cutaneous t-cell lymphoma pipeline 2026: fda updates, therapy innovations, and clinical trial landscape analysis by delveinsight |... Barchart Wed, 11 Mar 2026 14:34:07 GMT
• evlo financials: income statement, balance sheet & cash flow Stock Titan Tue, 10 Mar 2026 09:50:19 GMT
• scps financials: income statement, balance sheet & cash flow Stock Titan Tue, 03 Mar 2026 16:58:42 GMT
• vrpx financials: income statement, balance sheet & cash flow Stock Titan Mon, 02 Mar 2026 21:10:29 GMT
• vrpx financials: income statement, balance sheet & cash flow Stock Titan Sat, 28 Feb 2026 03:37:40 GMT
• scps financials: income statement, balance sheet & cash flow Stock Titan Tue, 24 Feb 2026 08:21:40 GMT
• scps financials: income statement, balance sheet & cash flow | scopus biopharma inc. Stock Titan Sun, 15 Feb 2026 14:56:39 GMT
• scopus biopharma in a holding pattern as turnaround progress hinges on ip and pipeline AD HOC NEWS Sun, 15 Feb 2026 08:00:00 GMT
• envista holdings corporation common stock (ny: nvst FinancialContent Wed, 29 Oct 2025 07:27:47 GMT
• driving health transformation: big pharma’s innovation labs revolution Springer Thu, 23 Oct 2025 07:00:00 GMT
• antisense oligonucleotide therapeutics pipeline outlook 2025: clinical trial studies, ema, pdma, fda approvals, moa, roa, nda, ind... The Globe and Mail Fri, 29 Aug 2025 17:13:45 GMT
• another key biotech firm files for bankruptcy; will liquidate TheStreet Wed, 27 Aug 2025 03:55:59 GMT
• a clinical consensus statement on pulmonary recurrent respiratory papillomatosis - kohli - the laryngoscope Wiley Online Library Fri, 01 Aug 2025 07:00:00 GMT
• antisense oligonucleotide therapeutics pipeline appears robust with 15+ key pharma companies actively working in the therapeutics ... Barchart.com Tue, 15 Jul 2025 07:00:00 GMT
• elon musk supports warren buffett’s idea to ban all members of congress from re-election if the deficit exceeds 3% of u.s. gdp The Globe and Mail Thu, 05 Jun 2025 17:08:00 GMT
• silver prices rocket to 13-year highs. more upside is likely. The Globe and Mail Thu, 05 Jun 2025 16:54:00 GMT
• csx corporation stock: is csx underperforming the industrial sector? The Globe and Mail Thu, 05 Jun 2025 16:37:00 GMT
• crude prices gain on dollar weakness and hopes of easing us-china trade tensions The Globe and Mail Thu, 05 Jun 2025 15:47:00 GMT
• dear amd stock fans, mark your calendars for june 12 The Globe and Mail Thu, 05 Jun 2025 14:16:00 GMT
• zefiro appoints catherine flax as its interim chief executive officer The Globe and Mail Thu, 05 Jun 2025 12:59:00 GMT
• mckesson stock: is mck outperforming the healthcare sector? The Globe and Mail Thu, 05 Jun 2025 07:17:00 GMT
• gran tierra energy announces sale of gran tierra north sea limited The Globe and Mail Wed, 04 Jun 2025 21:30:00 GMT
• brookfield to advance ai infrastructure in sweden through sek 95 billion investment The Globe and Mail Wed, 04 Jun 2025 10:56:00 GMT
• americold elevates proven leaders to drive operational excellence and global growth The Globe and Mail Mon, 02 Jun 2025 20:30:00 GMT
• apollo partners with major banks to boost private credit trading The Globe and Mail Mon, 02 Jun 2025 17:08:00 GMT
• cotton rallying early on monday, with help from outside factors The Globe and Mail Mon, 02 Jun 2025 12:34:00 GMT
• auric minerals corp. announces closing of property transaction The Globe and Mail Mon, 02 Jun 2025 11:30:00 GMT
• 1 no-brainer artificial intelligence (ai) etf to buy with $50 during the s&p 500 bull market The Globe and Mail Sun, 01 Jun 2025 08:29:00 GMT
• hogs surge while cattle markets fall at month end The Globe and Mail Sat, 31 May 2025 00:51:00 GMT
• s&p futures slip after trump hits out at china, u.s. pce inflation data in focus The Globe and Mail Fri, 30 May 2025 09:54:00 GMT
• beyond the hype: 2 top under-the-radar ai stocks to watch in 2025 The Globe and Mail Fri, 30 May 2025 07:00:00 GMT
• elon musk thinks tesla will be the world's most valuable company, but this huge problem could send its stock plunging by 70% inste... The Globe and Mail Fri, 30 May 2025 07:00:00 GMT
• zacks industry outlook highlights tetra tech, atmus filtration technologies, energy recovery and liqtech international The Globe and Mail Thu, 29 May 2025 10:30:00 GMT
• stocks fall as president trump expands chip software restrictions on china The Globe and Mail Wed, 28 May 2025 07:00:00 GMT
• 3 high-yield dividend stocks to buy to cash in on this exciting $500 billion opportunity The Globe and Mail Wed, 28 May 2025 07:00:00 GMT
• rckt stock tanks on patient death in danon disease study The Globe and Mail Wed, 28 May 2025 07:00:00 GMT
• can nvidia stock hit new heights? ceo jensen huang just provided clear and compelling evidence that the answer is "yes." The Globe and Mail Wed, 28 May 2025 07:00:00 GMT
• soligenix (nasdaq: sngx) innovative treatment to combat bacterial infection fills urgent need for alternatives to antibiotics The Globe and Mail Tue, 27 May 2025 07:00:00 GMT
• if you have any doubts over tesla's ambitions in artificial intelligence (ai), this 1 word from nvidia ceo jensen huang should cha... The Globe and Mail Tue, 27 May 2025 07:00:00 GMT
• carter bank completes the purchase of two first reliance bank branches in north carolina The Globe and Mail Tue, 27 May 2025 07:00:00 GMT
• 3 crypto-centric stocks in focus as bitcoin resumes its rally The Globe and Mail Tue, 27 May 2025 07:00:00 GMT
• jpmorgan beefs up tech team as it eyes new sector deals The Globe and Mail Sat, 24 May 2025 07:00:00 GMT
• investing in dividend stocks: the stability of warren buffett's picks The Globe and Mail Sat, 24 May 2025 07:00:00 GMT
• framework to identify innovative sources of value creation from platform technologies PNAS Sat, 24 May 2025 06:25:19 GMT
• openai’s $6.5b deal with jony ive hints at a post-iphone ai era The Globe and Mail Fri, 23 May 2025 07:00:00 GMT
• sugar prices fall on projections for record global sugar production The Globe and Mail Fri, 23 May 2025 07:00:00 GMT
• are options traders betting on a big move in the boston beer company (sam) stock? The Globe and Mail Fri, 23 May 2025 07:00:00 GMT
• prediction: 3 stocks that'll be worth more than apple 5 years from now The Globe and Mail Tue, 13 May 2025 07:00:00 GMT
• freshpet misses earnings estimates in q1, lowers 2025 guidance The Globe and Mail Tue, 06 May 2025 07:00:00 GMT
• tesla's affordable ev: do the latest details make the stock a buy? The Globe and Mail Mon, 05 May 2025 07:00:00 GMT
• uber is launching its own robotaxi fleet with volkswagen. is uber a better buy than tsla stock? The Globe and Mail Wed, 30 Apr 2025 07:00:00 GMT
• wall street is screaming to buy nvidia stock hand over fist right now. should you listen? The Globe and Mail Fri, 25 Apr 2025 07:00:00 GMT
• is brookfield asset management stock a millionaire-maker? The Globe and Mail Tue, 22 Apr 2025 07:00:00 GMT
• cutaneous t-cell lymphoma (ctcl) treatment market 2034: clinical trials, medication, prevalence, statistics, revenue, therapies, e... Barchart.com Fri, 28 Mar 2025 07:00:00 GMT
• should you buy the dip in tesla stock in march 2025? The Globe and Mail Mon, 24 Mar 2025 07:00:00 GMT
• scopus biopharma : announces pricing of $9 million follow-on public offering -january 26, 2021 at 08:01 pm est marketscreener.com Fri, 07 Mar 2025 22:33:44 GMT
• preparing for a new era in the rare disease sector European Pharmaceutical Review Fri, 28 Feb 2025 08:00:00 GMT
• wellgistics health, inc. announces pricing of $4.0 million initial public offering The Globe and Mail Fri, 21 Feb 2025 08:00:00 GMT
• scopus biopharma adjourns its annual general meeting of shareholders -october 27, 2021 at 06:13 am edt Marketscreener.com Wed, 12 Feb 2025 06:21:12 GMT
• contrasting scopus biopharma (nasdaq:scps) & elite pharmaceuticals (otcmkts:eltp) Defense World Thu, 23 Jan 2025 08:00:00 GMT
• canoo inc. (nasdaq:goev) receives $108.10 consensus price target from brokerages Defense World Thu, 23 Jan 2025 08:00:00 GMT
• analyzing cerro grande mining (otcmkts:cegmf) and niocorp developments (nasdaq:nb) Defense World Thu, 23 Jan 2025 08:00:00 GMT
• investors buy large volume of put options on ishares u.s. real estate etf (nysearca:iyr) Defense World Thu, 23 Jan 2025 06:11:41 GMT
• janus henderson group (nyse:jhg) versus abacus life (nasdaq:abl) financial comparison Defense World Thu, 23 Jan 2025 06:11:37 GMT
• contrasting ucommune international (nasdaq:uk) and optimizerx (nasdaq:oprx) Defense World Thu, 23 Jan 2025 06:11:15 GMT
• metavista3d announces 3d enhancement capabilities with iphone's new spatial feature The Globe and Mail Thu, 16 Jan 2025 08:00:00 GMT
• is nvidia stock a buy, sell, or hold on the run.ai acquisition? The Globe and Mail Thu, 02 Jan 2025 08:00:00 GMT
• scps (scopus biopharma) profitability rank : 0 (as of jun. 2023) GuruFocus.com Sun, 01 Dec 2024 11:35:24 GMT
• keysight technologies, inc. (nyse:keys) given consensus rating of “moderate buy” by brokerages Defense World Wed, 27 Nov 2024 09:52:33 GMT
• rxsight, inc. (nasdaq:rxst) given consensus recommendation of “buy” by analysts Defense World Wed, 27 Nov 2024 08:00:00 GMT
• glacier bancorp, inc. (nasdaq:gbci) given average recommendation of “hold” by brokerages Defense World Wed, 27 Nov 2024 08:00:00 GMT
• topgolf callaway brands corp. (nyse:modg) given average recommendation of “hold” by brokerages Defense World Wed, 27 Nov 2024 07:49:07 GMT
• tesla, inc. (nasdaq:tsla) receives $230.18 average pt from brokerages Defense World Wed, 27 Nov 2024 07:49:07 GMT
• olema pharmaceuticals, inc. (nasdaq:olma) given average recommendation of “buy” by brokerages Defense World Wed, 27 Nov 2024 07:49:07 GMT
• bird construction inc. (tse:bdt) receives average rating of “moderate buy” from analysts Defense World Wed, 27 Nov 2024 07:49:07 GMT
• financial contrast: medical properties trust (nyse:mpw) versus cubesmart (nyse:cube) Defense World Wed, 27 Nov 2024 07:49:07 GMT
• broadridge financial solutions, inc. (nyse:br) given consensus recommendation of “hold” by analysts Defense World Wed, 27 Nov 2024 07:49:07 GMT
• valley national bancorp (nasdaq:vly) receives average rating of “hold” from brokerages Defense World Wed, 27 Nov 2024 07:49:07 GMT
• matador resources (nyse:mtdr) given average recommendation of “moderate buy” by analysts Defense World Wed, 27 Nov 2024 07:49:07 GMT
• 2024: the year ai drug discovery and protein structure prediction took center stage—2025 set to amplify growth drugdiscoverytrends.com Mon, 25 Nov 2024 08:00:00 GMT
• detroit's iconic renaissance center could see 2 towers razed in $1.6b redevelopment plan The Globe and Mail Mon, 25 Nov 2024 08:00:00 GMT
• got $10,000? this super-high-yield dividend etf could turn it into over $90 of passive income each month. The Globe and Mail Sun, 24 Nov 2024 08:00:00 GMT
• brainsway (nasdaq:bway) rating reiterated by hc wainwright Defense World Wed, 23 Oct 2024 07:00:00 GMT
• scopus biopharma announces ind submission to fda for lead drug candidate Quantisnow Sun, 30 Jun 2024 09:39:59 GMT
• scopus biopharma to present at h.c. wainwright 23rd annual global investment conference Quantisnow Sun, 30 Jun 2024 09:38:57 GMT
• scopus biopharma announces fda approval of ind application for lead drug candidate Quantisnow Sun, 30 Jun 2024 09:34:51 GMT
• scopus biopharma's subsidiary — duet therapeutics — set to release scientific data during the 17th annual ... Quantisnow Sun, 30 Jun 2024 09:14:25 GMT
• scopus biopharma announces adjournment of annual meeting of stockholders Quantisnow Sun, 30 Jun 2024 09:14:20 GMT
• scopus biopharma announces closing of underwriters' over-allotment option in full Quantisnow Sun, 30 Jun 2024 04:40:37 GMT
• scopus biopharma to adjourn 2021 annual meeting of stockholders Quantisnow Sun, 30 Jun 2024 03:33:24 GMT
• scopus biopharma announces new date for 2021 annual meeting of stockholders Quantisnow Sun, 30 Jun 2024 01:17:00 GMT
• scopus biopharma announces pricing of $9 million follow-on public offering Quantisnow Sun, 30 Jun 2024 01:16:21 GMT
• scopus biopharma announces completion of clinical lot manufacture Quantisnow Sun, 30 Jun 2024 01:13:34 GMT
• scopus biopharma announces adjournment of annual meeting of stockholders Quantisnow Sat, 29 Jun 2024 23:38:44 GMT
• scopus biopharma finalizes arrangements for submission of ind package Quantisnow Sat, 29 Jun 2024 23:32:43 GMT
• scopus biopharma's subsidiary — duet therapeutics — announces release of preclinical data being presented at ... Quantisnow Sat, 29 Jun 2024 23:31:09 GMT
• scopus biopharma announces new management appointment following acquisition of leading immunotherapy ... Quantisnow Sat, 29 Jun 2024 23:30:46 GMT
• china national intellectual property administration grants new patent covering duet-02, one of three key cpg ... Quantisnow Sat, 29 Jun 2024 23:29:38 GMT
• scopus biopharma sends letter urging stockholders to vote "for all" of the company's director nominees on the ... Quantisnow Sat, 29 Jun 2024 18:06:14 GMT
• solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects Frontiers Wed, 26 Jun 2024 02:21:48 GMT
• why nvidia stock is not like cisco before the dot-com bubble burst The Globe and Mail Tue, 25 Jun 2024 07:00:00 GMT
• non-hodgkin lymphoma market 2034: epidemiology trends, innovativ News Channel Nebraska Wed, 19 Jun 2024 07:00:00 GMT
• nitric oxide synthase inducible – drugs in development, 2024 GlobalData Wed, 05 Jun 2024 07:00:00 GMT
• nitric oxide synthase inducible - drugs in development, 2024 - market research reports & consulting GlobalData Wed, 05 Jun 2024 07:00:00 GMT
• cutaneous t-cell lymphoma (ctcl) market size was usd 520 million in 2023, estimates delveinsight Barchart Mon, 27 May 2024 10:46:00 GMT
• navidea biopharmaceuticals (navb) stock trends and sentiment 2025 MarketBeat Sun, 26 May 2024 18:16:55 GMT
• genocea biosciences (gncaq) stock trends and sentiment 2025 MarketBeat Sun, 26 May 2024 04:49:58 GMT
• could the scopus biopharma inc. (nasdaq:scps) ownership structure tell us something useful? Yahoo Movies UK Wed, 01 May 2024 13:08:07 GMT
• could the scopus biopharma inc. (nasdaq:scps) ownership structure tell us something useful? Yahoo Movies UK Mon, 29 Apr 2024 13:08:07 GMT
• cutaneous t-cell lymphoma (ctcl) market size was usd 520 million in 2023, estimates delveinsight | 4sc, bio-path holdings, bioinve... Barchart.com Thu, 25 Apr 2024 07:00:00 GMT
• scorpius holdings, inc. (scpx) stock price, news, quote & history Yahoo! Finance Canada Fri, 05 Apr 2024 16:58:00 GMT
• latest developments in non-hodgkin's lymphoma pipeline in 2024: analysis of clinical trials, therapies ... Barchart Wed, 20 Mar 2024 11:50:00 GMT
• pharmaceutical and biotechnology royalty rates report 2024: essential benchmark data for dealmakers - royalty ... PR Newswire Thu, 14 Mar 2024 00:00:00 GMT
• pharmaceutical and biotechnology royalty rates report and directory 2024: technology licensed, license fees, upfront and milestone... Business Wire Wed, 13 Mar 2024 07:00:00 GMT
Scopus BioPharma Inc(NASDAQ:SCPS) 
Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives...
Website: https://scopusbiopharma.com/
Founded: 2017
Full Time Employees: 1 (May 2021)
CEO: Joshua R. Lamstein
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends